{
 "edition": "20261008-18",
 "language": "en",
 "period_start": "2026-10-08T18:00:00+09:00",
 "period_end": "2026-10-08T21:00:00+09:00",
 "page": 4,
 "pages": 4,
 "received_in_period": 321,
 "listed_in_period": 321,
 "description": "One place for news and notices from 2 countries/regions: Taiwan, 206 items from 6 sources; Japan, 115 items from 1 source.One edition every 180 minutes: every item from every source received in the period, with the original link.",
 "countries": [
  {
   "code": "TW",
   "name": "Taiwan",
   "items": 206,
   "sources": 6
  },
  {
   "code": "JP",
   "name": "Japan",
   "items": 115,
   "sources": 1
  }
 ],
 "number_of_items": 21,
 "items": [
  {
   "id": 3264737,
   "anchor": "n3264737",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264737",
   "title": "憶聲電子 September revenue rises 37% month over month and 54% year over year to 104 million yuan as operating momentum recovers",
   "title_state": "translated",
   "summary": "憶聲電子(3024-TW) announced that its September 2026 revenue reached NT$104 million, up 37% month over month and 54% year over year, signaling a recovery in operating momentum. Marking its 50th anniversary, the company is advancing its “333 transformation strategy” and assessing AI applications to strengthen its medium- to long-term competitiveness.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "憶聲電子's September 2026 unaudited consolidated revenue was NT$104 million.",
     "state": "translated",
     "quote": "2026年9月自結合併營收為新台幣1.04億元"
    },
    {
     "text": "憶聲電子's September revenue increased 37% from the previous month.",
     "state": "translated",
     "quote": "較上月增加37%"
    },
    {
     "text": "憶聲電子's September revenue grew 54% year over year",
     "state": "translated",
     "quote": "較去年同期成長54%"
    },
    {
     "text": "憶聲電子 is advancing its “333 Transformation Strategy”",
     "state": "translated",
     "quote": "公司近年積極推動「333轉型戰略」"
    },
    {
     "text": "憶聲電子 will mark its 50th anniversary in October 2026",
     "state": "translated",
     "quote": "適逢今年10月公司成立50週年"
    }
   ],
   "companies": [
    "憶聲電子",
    "憶聲電子(3024-TW)"
   ],
   "published_at": "2026-10-08T17:40:13+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624780",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289095-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264736,
   "anchor": "n3264736",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264736",
   "title": "華碩 Q3 revenue hit a record 2763億元; some server project shipments delayed until October",
   "title_state": "translated",
   "summary": "華碩(2357-TW)公布第三季營收2,763億元創歷史新高，年增近四成。儘管部分伺服器專案遞延至10月出貨，但法人看好其轉向高階市場策略及強勁伺服器業務，預期未來營運將持續走強。",
   "summary_state": "original",
   "facts": [
    {
     "text": "華碩's September consolidated revenue was 972億元, up 18% year over year and about 2.36% month over month",
     "state": "translated",
     "quote": "華碩9月集團營收972億元，年增18%、月增約2.36%"
    },
    {
     "text": "華碩's third-quarter consolidated revenue was 2,763億元, up 38% year over year and about 7.2% quarter over quarter",
     "state": "translated",
     "quote": "第三季集團營收2,763億元，年增38%、季增約7.2%"
    },
    {
     "text": "華碩's consolidated revenue for the first three quarters of this year totaled about 7,424億元, up about 38.51% year over year",
     "state": "translated",
     "quote": "今年累計前三季集團營收約7,424億元，年增約38.51%"
    },
    {
     "text": "Some of 華碩's server project shipments were delayed until October to align with customers' data center construction schedules",
     "state": "translated",
     "quote": "目前尚有部分伺服器專案配合客戶資料中心建置時程，遞延至10月出貨"
    },
    {
     "text": "華碩's strategy has now shifted toward the high-end market, which is expected to boost profits",
     "state": "translated",
     "quote": "華碩目前策略已轉往高階市場，有望帶動獲利提升"
    }
   ],
   "companies": [
    "華碩",
    "2357-TW"
   ],
   "published_at": "2026-10-08T17:40:13+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624843",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289101-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264738,
   "anchor": "n3264738",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264738",
   "title": "Bicycle maker 巨大 reports September revenue of 53.68億元, up 3% year over year; cumulative revenue decline narrows",
   "title_state": "translated",
   "summary": "巨大 Group reported September 2026 revenue of 53.68億元, up 2.88% year over year, with the cumulative decline narrowing. Performance in the Chinese mainland market was strong, while revenue in the United States and contract manufacturing business fell due to geopolitical factors and orders.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "巨大 Group's September 2026 revenue was 53.68億元, up 2.88% year over year.",
     "state": "translated",
     "quote": "2026年9月營收53.68億元，月增3.51%，年成長 2.88%"
    },
    {
     "text": "巨大 Group's cumulative revenue for January-September 2026 declined 5.13% year over year.",
     "state": "translated",
     "quote": "2026年1-9月累計營收454.99億元，年減幅度持續收斂至 5.13%"
    },
    {
     "text": "巨大 Group's September revenue in the Chinese mainland grew 26% month over month, driven by strong demand for mountain bikes and electric vehicles.",
     "state": "translated",
     "quote": "在中國大陸市場，登山車和電動車銷售暢旺，轉換台幣後，帶動單月營收成長26%"
    },
    {
     "text": "巨大 Group's U.S. revenue continued to decline in September, affected by the WRO incident and the Iran war.",
     "state": "translated",
     "quote": "美國市場持續受到 WRO 事件影響，及伊朗戰爭影響消費者信心，單月營收仍呈現衰退"
    },
    {
     "text": "巨大 Group's contract manufacturing revenue edged down in September, mainly due to the WRO issue and fewer customer orders.",
     "state": "translated",
     "quote": "而巨大9月在代工（OE）業務方面，單月營收表現較去年同期微幅減少，主要歸因於WRO問題的影響以及客戶訂單減少"
    }
   ],
   "companies": [
    "巨大",
    "巨大(9921-TW)"
   ],
   "published_at": "2026-10-08T17:32:23+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624847",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289102-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264739,
   "anchor": "n3264739",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264739",
   "title": "光寶科9月營收188億元年增逾2成 AI伺服器電源系統出貨暢旺",
   "title_state": "original",
   "summary": "Power supply maker 光寶科 (2301-TW) reported September revenue of 188億元, up 22% year over year, benefiting from strong demand for power management systems including AI server power supplies and BBUs. Third-quarter revenue was 573.98億元, up 27.9% year over year, while revenue for the first three quarters totaled 1,536億元, up 26%.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "光寶科's September revenue was 188億元, up 22% year over year.",
     "state": "translated",
     "quote": "光寶科9月營收188億元，月減約4%，年增22%"
    },
    {
     "text": "光寶科's third-quarter revenue was 573.98億元, up about 27.9% year over year.",
     "state": "translated",
     "quote": "第三季營收573.98億元，季增約8.9%、年增約27.9%"
    },
    {
     "text": "光寶科's cumulative revenue for the first three quarters of this year was 1,536億元, up 26% year over year.",
     "state": "translated",
     "quote": "今年累計前三季營收1,536億元，年增26%"
    },
    {
     "text": "雲端及物聯網部門9月營收佔比達59%，年增逾五成。",
     "state": "original",
     "quote": "雲端及物聯網部門九月份營收佔比達59%；其中，AI、雲端運算及高階伺服器、網通等電能管理系統出貨暢旺，帶動雲端及物聯網部門營收年增逾五成"
    },
    {
     "text": "光電部門9月營收佔整體14%，年成長達一成。",
     "state": "original",
     "quote": "光電部門營收佔整體之14%；其中，高階光耦合器於工控、新能源與AI伺服器電能管理系統需求成長；以及高階可見光受惠於高集成、微型化指示燈應用於 AI 伺服器與交換器之需求穩定成長，共同推升光電部門年成長達一成"
    },
    {
     "text": "The information and consumer electronics division accounted for 27% of September revenue, benefiting from steady growth in demand for low-Earth-orbit satellites and high-end power supplies.",
     "state": "translated",
     "quote": "資訊及消費性電子部門營收佔整體之27%；受惠應用市場多元化，低軌衛星與高階電源需求穩定成長"
    }
   ],
   "companies": [
    "光寶科"
   ],
   "published_at": "2026-10-08T17:31:06+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624856",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289103-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264740,
   "anchor": "n3264740",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264740",
   "title": "〈China Stocks After the Close〉CPO and semiconductor stocks lead declines; Shanghai Composite ends 2-day winning streak",
   "title_state": "translated",
   "summary": "China's three major A-share indexes fell today (8) to make up ground after the long holiday, with the ChiNext leading declines and the Shanghai Composite ending its 2-day winning streak. Semiconductor and CPO stocks led losses, while oil and petrochemical, banking, solid-state battery and shipping stocks rose against the trend.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "The Shanghai Composite closed down 0.79% at 3811.9 points, ending a 2-consecutive-trading-day advance",
     "state": "translated",
     "quote": "上證指數(SSEC)亦結束連2個交易日走漲氣勢"
    },
    {
     "text": "The ChiNext Index closed down 3.15% at 3036.66 points, while the STAR 50 Index fell 4.82% to 1456.32 points",
     "state": "translated",
     "quote": "創業板指收跌3.15%至3036.66點，科創50指數收黑4.82%至1456.32點"
    },
    {
     "text": "Turnover on the Shanghai and Shenzhen markets totaled 1.68 trillion yuan, up 2441億元 from the previous trading day",
     "state": "translated",
     "quote": "滬深兩市成交額人民幣1.68兆元，較上一交易日放量2441億元"
    },
    {
     "text": "AI hardware stocks including semiconductors and CPO led declines; 源傑科技, 長光華芯, 東山精密, 沃格光電 and 均勝電子 hit the daily limit down",
     "state": "translated",
     "quote": "半導體、CPO等AI硬體股表現不佳……源傑科技、長光華芯、東山精密、沃格光電、均勝電子等股跌停"
    },
    {
     "text": "DRAM leader 長鑫科技 fell more than 8% intraday",
     "state": "translated",
     "quote": "DRAM龍頭長鑫科技盤中跌超8%"
    },
    {
     "text": "中國銀行, 工商銀行 and 杭州銀行 hit record highs intraday",
     "state": "translated",
     "quote": "中國銀行、工商銀行、杭州銀行日內創歷史新高"
    },
    {
     "text": "中遠海能 and 招商南油 hit the daily limit up",
     "state": "translated",
     "quote": "航運類股亦表現佳，中遠海能、招商南油漲停"
    },
    {
     "text": "阿里巴巴 and 智譜 completed financings of about 800億港元 and 50億美元, respectively",
     "state": "translated",
     "quote": "阿里巴巴、智譜分別完成約800億港元、50億美元融資"
    }
   ],
   "companies": [
    "源傑科技",
    "長光華芯",
    "東山精密",
    "沃格光電",
    "均勝電子",
    "天孚通訊",
    "長鑫科技",
    "思瑞浦",
    "微導奈米",
    "聖邦股份",
    "博邁科",
    "通源石油",
    "國新能源",
    "廣西能源",
    "中國銀行",
    "工商銀行",
    "杭州銀行",
    "力王股份",
    "雄韜股份",
    "豐元股份",
    "領湃科技",
    "傳藝科技",
    "紫竹高科",
    "中遠海能",
    "招商南油",
    "華泰證券",
    "長江證券",
    "中信建投",
    "阿里巴巴",
    "智譜",
    "騰訊",
    "OpenAI",
    "Anthropic"
   ],
   "published_at": "2026-10-08T17:30:02+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624762",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289097-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264741,
   "anchor": "n3264741",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264741",
   "title": "〈Top Five Electronics Makers' Revenue〉AI servers drive quarter-by-quarter growth at 緯創; Q3 revenue surges to a record 1.15兆元 for a single quarter",
   "title_state": "translated",
   "summary": "緯創公告9月營收年增逾8成，受惠AI伺服器需求強勁，第三季營收創1.15兆元歷史新高，累計前三季營收亦大幅增長。",
   "summary_state": "original",
   "facts": [
    {
     "text": "緯創's third-quarter revenue reached 1.15兆元, a record high for a single quarter.",
     "state": "translated",
     "quote": "第三季營收再度站上兆元關卡，達1.15兆元，年增逾1倍，創下歷史單季新高紀錄。"
    },
    {
     "text": "緯創's September revenue was 3,808.06億元, up 87.19% year over year.",
     "state": "translated",
     "quote": "緯創9月營收3808.06億元，月減17.22%，年增87.19%"
    },
    {
     "text": "緯創's AI servers are the company's main growth engine, and operations are expected to peak in the fourth quarter.",
     "state": "translated",
     "quote": "AI伺服器仍為公司主要成長引擎，推升今年營運呈現逐季向上，並在第四季迎來高峰。"
    },
    {
     "text": "緯創 shipped 1.5 million laptops in September, down 31.82% year over year.",
     "state": "translated",
     "quote": "緯創9月筆電出貨150萬台，月增7.14%，年減31.82%"
    },
    {
     "text": "緯創's cumulative revenue for the first three quarters of this year was 2.89兆元, up 97.25% year over year.",
     "state": "translated",
     "quote": "累計今年前三季營收2.89兆元，年增97.25%，同步改寫歷史同期高。"
    }
   ],
   "companies": [
    "緯創"
   ],
   "published_at": "2026-10-08T17:29:46+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624855",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289104-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264742,
   "anchor": "n3264742",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264742",
   "title": "Trump administration tightens visa rules again! International students seeking U.S. work may face a 7萬美元 internship fee",
   "title_state": "translated",
   "summary": "The U.S. Department of Homeland Security has proposed sharply raising the OPT internship fee for international students to 7萬美元 as part of the Trump administration's visa crackdown, aiming to protect U.S. workers and combat fraud. The proposal is expected to face legal challenges.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "The U.S. Department of Homeland Security has proposed requiring international students in OPT to pay an internship fee of at least 7萬美元",
     "state": "translated",
     "quote": "根據提案，持F-1非移民學生簽證的外籍學生，須向認證機構支付7萬美元，才能參加稱為「選擇性實習訓練」（Optional Practical Training，OPT）的在職訓練"
    },
    {
     "text": "An additional 3萬美元 would also be required for participation in further job training",
     "state": "translated",
     "quote": "若要接受額外工作訓練，還須支付3萬美元"
    },
    {
     "text": "Those participating in OPT currently pay about 500美元 in fees",
     "state": "translated",
     "quote": "目前參加者須支付的費用約為500美元"
    },
    {
     "text": "The new rules aim to combat fraud, strengthen the integrity of the immigration system and protect U.S. workers",
     "state": "translated",
     "quote": "國土安全部表示，新規旨在「打擊詐欺、強化移民制度的健全性，並保護美國勞工」"
    },
    {
     "text": "The proposal is subject to a 30-day public comment period; implementation would begin 60 days after it is finalized",
     "state": "translated",
     "quote": "這項提案須先經過30天的公眾意見徵詢期，才能定案。國土安全部表示，規則定案後將再等60天才實施"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T17:20:02+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624803",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289099-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264743,
   "anchor": "n3264743",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3264743",
   "title": "China-EU trade talks begin in Beijing as EU takes tougher stance on deficit",
   "title_state": "translated",
   "summary": "The EU and China will hold trade talks in Beijing, focusing on a daily trade deficit of more than 10億歐元 and restrictions on rare earths. Hardliners within the EU are calling for a “credible tool” to address potential trade conflicts, while Beijing has issued a stern warning against protectionism and vowed to retaliate.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "The EU and China are set to hold two-day trade talks in Beijing.",
     "state": "translated",
     "quote": "歐盟與中國即將於北京展開為期兩天的貿易談判"
    },
    {
     "text": "EU Trade Commissioner Maroš Šefčovič has arrived in Beijing for talks with China's Commerce Minister 王文濤.",
     "state": "translated",
     "quote": "歐盟貿易事務委員謝夫喬維奇(Maros Sefcovic)已抵達北京，本周將與中國商務部長王文濤展開為期兩天的貿易談判"
    },
    {
     "text": "The EU faces a massive trade deficit of more than 10億歐元 a day.",
     "state": "translated",
     "quote": "本次會談的核心在於化解歐盟每天高達逾10億歐元的巨額貿易逆差"
    },
    {
     "text": "French President Emmanuel Macron and German Chancellor Friedrich Merz jointly proposed establishing a deterrent “credible tool.”",
     "state": "translated",
     "quote": "法國總統馬克宏(Emmanuel Macron)與德國總理梅爾茨(Friedrich Merz)聯合向歐盟提議，應建立一套具威懾力的「可信工具」"
    },
    {
     "text": "The European Commission is preparing defensive measures, including tariff quotas, on Chinese hybrid vehicles.",
     "state": "translated",
     "quote": "歐盟執委會正準備對中國油電混合動力車實施關稅配額等防衛限制措施"
    },
    {
     "text": "China's Ministry of Commerce warned France and Germany against turning to protectionism.",
     "state": "translated",
     "quote": "中國商務部要求法德兩國切勿轉向「保護主義」"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T17:10:04+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624770",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289105-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265132,
   "anchor": "n3265132",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265132",
   "title": "Taiwan stocks weekly TOP 15: 10/02-10/08 (gainers) 浩鼎 27.86%, 瑞基 21.41%, 泰福-KY 14.7% - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "2026年10月2日至8日台股上市櫃近一周漲幅TOP 15排行，浩鼎以27.86%居首，瑞基與泰福-KY分別為21.41%及14.70%，並列出近一月漲幅排行。",
   "summary_state": "original",
   "facts": [],
   "companies": [
    "浩鼎",
    "瑞基",
    "泰福-KY",
    "松瑞藥",
    "亞諾法",
    "益得",
    "合世",
    "永笙-KY",
    "太景*-KY",
    "馬光-KY",
    "國光生",
    "華安",
    "南光",
    "豪展",
    "金萬林-創",
    "睿生光電",
    "禾榮科",
    "圓祥生技",
    "全福生技",
    "漢達",
    "基米-創",
    "浩宇生醫",
    "漢康-KY創",
    "基亞"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90623&kind=20",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289854-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265131,
   "anchor": "n3265131",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265131",
   "title": "Institutional investors' weekly activity: 10/02-10/08 (net buying) 松瑞藥 3776 lots, 國光生 1978 lots, 東洋 1243 lots; (net selling) 康霈 2450 lots, 浩鼎 1449 lots, 漢達 913 lots - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "Net buying and selling by the three major institutional investors from October 2 to 8, 2026: 松瑞藥, 國光生 and 東洋 were the top three net buys; 康霈, 浩鼎 and 漢達 were the top three net sells.",
   "summary_state": "translated",
   "facts": [],
   "companies": [
    "松瑞藥",
    "國光生",
    "東洋",
    "康霈",
    "浩鼎",
    "漢達",
    "中天",
    "大江",
    "健喬",
    "沛爾生醫*-創",
    "晟德",
    "國邑*",
    "晶碩",
    "台耀",
    "藥華藥",
    "視陽",
    "泰博",
    "保瑞",
    "麗豐-KY",
    "禾榮科"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90624&kind=20",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289856-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265130,
   "anchor": "n3265130",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265130",
   "title": "A look at popular emerging-stock market names from 10/02-10/08—仁新*, 安成生技 and 樂迦再生—and top gainers 鼎晉生技, 寶泰生醫 and 安成生技 - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "A look at popular emerging-stock market names and top gainers from 10/02-10/08: 仁新*, 安成生技 and 樂迦再生 were actively traded, while 鼎晉生技 led with a gain of 62.49%.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "62.49%",
     "state": "translated",
     "quote": "62.49%"
    },
    {
     "text": "24.85%",
     "state": "translated",
     "quote": "24.85%"
    },
    {
     "text": "20.92%",
     "state": "translated",
     "quote": "20.92%"
    }
   ],
   "companies": [
    "仁新*",
    "安成生技",
    "樂迦再生",
    "鼎晉生技",
    "寶泰生醫",
    "仲恩生醫",
    "安基生技",
    "安立璽榮-KY",
    "瀚陽*",
    "水星生醫*",
    "新穎生醫",
    "禾生技",
    "視航生醫",
    "宣捷幹細胞",
    "大江基因"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90625&kind=20",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289851-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265129,
   "anchor": "n3265129",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265129",
   "title": "Biotech weekly roundup, 10/02-10/08: 鼎晉生技 gains 62.49%; 浩鼎 tops the list with a 27.86% rise - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "Biotech weekly roundup, 10/02-10/08: 鼎晉生技 gains 62.49%; 浩鼎 tops the list with a 27.86% rise",
   "summary_state": "translated",
   "facts": [
    {
     "text": "瑞基 (4171) ➡️ weekly gain of 21.41%",
     "state": "translated",
     "quote": "瑞基(4171)➡️週漲21.41%"
    },
    {
     "text": "泰福-KY (6541) ➡️ weekly gain of 14.7%",
     "state": "translated",
     "quote": "泰福-KY(6541)➡️週漲14.7%"
    },
    {
     "text": "松瑞藥 (4167): 3776 lots",
     "state": "translated",
     "quote": "松瑞藥(4167)：3776張"
    },
    {
     "text": "國光生 (4142): 1978 lots",
     "state": "translated",
     "quote": "國光生(4142)：1978張"
    },
    {
     "text": "東洋 (4105): 1243 lots",
     "state": "translated",
     "quote": "東洋(4105)：1243張"
    },
    {
     "text": "寶泰生醫 (7850)➡️ weekly gain of 24.85%",
     "state": "translated",
     "quote": "寶泰生醫(7850)➡️週漲24.85%"
    },
    {
     "text": "安成生技 (6610)➡️ weekly gain of 20.92%",
     "state": "translated",
     "quote": "安成生技(6610)➡️週漲20.92%"
    },
    {
     "text": "仁新* (6696): 33883 lots",
     "state": "translated",
     "quote": "仁新*(6696)：33883張"
    },
    {
     "text": "安成生技 (6610): 18706 lots",
     "state": "translated",
     "quote": "安成生技(6610)：18706張"
    },
    {
     "text": "樂迦再生 (6891): 13901 lots",
     "state": "translated",
     "quote": "樂迦再生(6891)：13901張"
    }
   ],
   "companies": [
    "鼎晉生技",
    "浩鼎",
    "瑞基",
    "泰福-KY",
    "松瑞藥",
    "國光生",
    "東洋",
    "寶泰生醫",
    "安成生技",
    "仁新*",
    "樂迦再生",
    "睿生光電",
    "禾榮科",
    "圓祥生技",
    "全福生技",
    "漢達",
    "基米-創",
    "浩宇生醫",
    "亞諾法",
    "益得",
    "合世",
    "永笙-KY",
    "太景*-KY"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90626&kind=20",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289852-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265128,
   "anchor": "n3265128",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265128",
   "title": "10/08 Biotech Stock Update - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "The 10/08 Biotech Stock Update covers licensing, contracts and issuance matters involving 三福化, 聯亞藥, 心誠鎂, 原創生醫 and 泰合生技, as well as stocks that rose and fell that day and institutional net buying and selling.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "750萬-share capital increase before initial listing",
     "state": "translated",
     "quote": "初上市前現增750萬股案"
    },
    {
     "text": "Underwriting price of NT$105.6",
     "state": "translated",
     "quote": "承銷價105.6元"
    },
    {
     "text": "合世 9.77%",
     "state": "translated",
     "quote": "合世9.77%"
    },
    {
     "text": "金萬林-創 9.76%",
     "state": "translated",
     "quote": "金萬林-創9.76%"
    },
    {
     "text": "太景*-KY 9.12%",
     "state": "translated",
     "quote": "太景*-KY9.12%"
    },
    {
     "text": "天良 5.48%",
     "state": "translated",
     "quote": "天良5.48%"
    },
    {
     "text": "圓祥生技 5%",
     "state": "translated",
     "quote": "圓祥生技5%"
    },
    {
     "text": "台聯電 4.09%",
     "state": "translated",
     "quote": "台聯電4.09%"
    },
    {
     "text": "松瑞藥 2298 lots",
     "state": "translated",
     "quote": "松瑞藥2298張"
    },
    {
     "text": "健喬 1304 lots",
     "state": "translated",
     "quote": "健喬1304張"
    },
    {
     "text": "中天 570 lots",
     "state": "translated",
     "quote": "中天570張"
    },
    {
     "text": "康霈* 961 lots",
     "state": "translated",
     "quote": "康霈*961張"
    },
    {
     "text": "全福生技 282 lots",
     "state": "translated",
     "quote": "全福生技282張"
    },
    {
     "text": "漢達 242 lots",
     "state": "translated",
     "quote": "漢達242張"
    }
   ],
   "companies": [
    "三福化",
    "三福生醫",
    "Ainos",
    "聯亞藥",
    "生技中心",
    "心誠鎂",
    "原創生醫",
    "泰合生技",
    "合世",
    "金萬林-創",
    "太景*-KY",
    "天良",
    "圓祥生技",
    "台聯電",
    "松瑞藥",
    "健喬",
    "中天",
    "康霈*",
    "全福生技",
    "漢達"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90640&kind=20",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289849-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265127,
   "anchor": "n3265127",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265127",
   "title": "泰合生技 (6467) plans a 750萬-share capital increase before initial listing, with an underwriting price of NT$105.6 - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "泰合生技 (6467) announced an underwriting price of NT$105.6 per share for its new share issuance through a cash capital increase before initial listing, with 750萬 shares to be issued.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "Issue of 7,500,000 common shares",
     "state": "translated",
     "quote": "發行普通股7,500,000股"
    },
    {
     "text": "NT$105.6 per share",
     "state": "translated",
     "quote": "每股新台幣105.6元"
    },
    {
     "text": "Minimum underwriting price: NT$88 per share",
     "state": "translated",
     "quote": "最低承銷價格為每股新台幣88元"
    },
    {
     "text": "Weighted average price: NT$177.88",
     "state": "translated",
     "quote": "加權平均價格為新台幣177.88元"
    }
   ],
   "companies": [
    "泰合生技股份有限公司",
    "泰合生技",
    "臺灣證券交易所股份有限公司"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90635&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289859-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265126,
   "anchor": "n3265126",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265126",
   "title": "元勛 (7660) finance and accounting主管謝元勝 resigns - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "元勛 (7660) announced that finance and accounting主管謝元勝 has resigned for personal career planning reasons. The resignation takes effect on 115/10/08, and a successor will be announced after a board resolution.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "115/10/08",
     "state": "translated",
     "quote": "115/10/08"
    }
   ],
   "companies": [
    "元勛"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90636&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289855-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265125,
   "anchor": "n3265125",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265125",
   "title": "台寶生醫 (6892) corrects part of the information in its 115/06/09 investor conference presentation - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "台寶生醫 (6892) corrected information in its 115/06/09 investor conference presentation, removing descriptions of Taiwan as a manufacturing base and of a PIC/S GMP-grade facility. The company said its Zhubei cell production facility was built to PIC/S GMP standards and had previously received a TFDA pilot factory assessment, but it is now evaluating the introduction of a new process for the FAST CGT platform and will not apply for a GMP extension for the time being. This correction does not affect financial or business information.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "115/06/09 investor conference",
     "state": "translated",
     "quote": "115/06/09法說會"
    },
    {
     "text": "Date of occurrence: 115/10/08",
     "state": "translated",
     "quote": "事實發生日:115/10/08"
    },
    {
     "text": "Page 13",
     "state": "translated",
     "quote": "第13頁"
    },
    {
     "text": "ROC year 113, May 22",
     "state": "translated",
     "quote": "民國113年5月22日"
    },
    {
     "text": "ROC year 115, May 22",
     "state": "translated",
     "quote": "民國115年5月22日"
    }
   ],
   "companies": [
    "台寶生醫股份有限公司",
    "TFDA"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90637&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289853-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265124,
   "anchor": "n3265124",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265124",
   "title": "奧孟亞 (7776) invited to attend an investor conference hosted by 凱基證券 on 10/14 - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "奧孟亞 (7776) was invited to attend an investor conference hosted by 凱基證券 on Oct. 14, where it will discuss its R&D progress, business development results and market outlook.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "7776",
     "state": "translated",
     "quote": "7776"
    },
    {
     "text": "10/14",
     "state": "translated",
     "quote": "10/14"
    },
    {
     "text": "14 時 00 分",
     "state": "original",
     "quote": "14 時 00 分"
    }
   ],
   "companies": [
    "奧孟亞",
    "凱基證券"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90638&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289857-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265123,
   "anchor": "n3265123",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265123",
   "title": "岱宇 (1598) invited to attend the 20th QIC CEO Week hosted by 寬量國際 on 10/13 - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "岱宇 (1598) was invited to attend the 20th QIC CEO Week hosted by 寬量國際 on 10/13, where it will brief investors on its operations, financials and business information.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "10/13",
     "state": "translated",
     "quote": "10/13"
    },
    {
     "text": "20th QIC CEO Week",
     "state": "translated",
     "quote": "20th QIC CEO Week"
    }
   ],
   "companies": [
    "岱宇",
    "寬量國際"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90639&kind=21",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289858-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265117,
   "anchor": "n3265117",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265117",
   "title": "10/08 Biotech Stock Update - Global Bio & Investment Monthly",
   "title_state": "translated",
   "summary": "10/8 Biotech Stock Update: 三福化 signs a global licensing agreement with Ainos for low-dose oral interferon; 聯亞藥 terminates the technology licensing agreement for cancer drug UB-941; 心誠鎂 signs an international pharmaceutical master services agreement; 原創生醫 obtains a European invention patent; 泰合生技 plans a 750萬-share capital increase before initial listing.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "Cash capital increase plan for 750萬 shares",
     "state": "translated",
     "quote": "現增750萬股案"
    },
    {
     "text": "Underwriting price of NT$105.6",
     "state": "translated",
     "quote": "承銷價105.6元"
    }
   ],
   "companies": [
    "三福化",
    "三福生醫",
    "Ainos",
    "聯亞藥",
    "生技中心",
    "心誠鎂",
    "原創生醫",
    "泰合生技",
    "合世",
    "金萬林-創",
    "太景*-KY",
    "天良",
    "圓祥生技",
    "台聯電",
    "松瑞藥",
    "健喬",
    "中天",
    "康霈*",
    "全福生技",
    "漢達"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90640&range=news",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289861-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265169,
   "anchor": "n3265169",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265169",
   "title": "What should you do if prenatal screening detects a cleft lip and palate in the fetus? Doctor urges parents to follow “this” principle and give the child a chance - Heho Health",
   "title_state": "translated",
   "summary": "About 4 out of every 100 fetuses in Taiwan have an anomaly, including conditions such as cleft lip and palate; in the past, expectant parents often felt anxious or chose to terminate the pregnancy because they worried about treatment, caregiving and future discrimination.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "Per 100 fetuses",
     "state": "translated",
     "quote": "每 100 個胎兒"
    },
    {
     "text": "About 4",
     "state": "translated",
     "quote": "約 4 個"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T19:10:19+09:00",
   "source_type": "heho",
   "source_name": "Heho健康",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://heho.com.tw/archives/388010",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289883-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265237,
   "anchor": "n3265237",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-en-p4.html#n3265237",
   "title": "[Association Affairs Update] Thanks to Premier 卓榮泰, Minister 石崇良 and Director-General 陳亮妤 for providing an additional NT$250 million in funding to reward clinics that open during consecutive holidays; the association urges adherence to medical...",
   "title_state": "translated",
   "summary": "中華民國醫師公會全國聯合會 thanked 行政院, 衛福部 and 健保署 for providing an additional NT$250 million in funding to promote incentive payments for medical services during national holidays, supporting medical institutions that open to meet public demand and ease the burden on emergency departments.",
   "summary_state": "translated",
   "facts": [
    {
     "text": "NT$250 million",
     "state": "translated",
     "quote": "2.5億元"
    },
    {
     "text": "Additional 50%",
     "state": "translated",
     "quote": "加成 50%"
    }
   ],
   "companies": [
    "中華民國醫師公會全國聯合會",
    "衛福部",
    "行政院",
    "健保署"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "tma",
   "source_name": "中華民國醫師公會全國聯合會",
   "country": "TW",
   "country_name": "Taiwan",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.tma.tw/meeting/meeting_info.asp?/14806.html",
   "link_level": "source",
   "link_label": "Original",
   "site_url": "https://ainews.idaeo.ai/a/4289927-en.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}